Recent advances in targeted therapies in acute myeloid leukemia
Bhansali, Rahul S, Pratz, Keith W, Lai, Catherine
Published in Journal of hematology and oncology (25.03.2023)
Published in Journal of hematology and oncology (25.03.2023)
Get full text
Journal Article
Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study
DiNardo, Courtney D, Pratz, Keith W, Letai, Anthony, Jonas, Brian A, Wei, Andrew H, Thirman, Michael, Arellano, Martha, Frattini, Mark G, Kantarjian, Hagop, Popovic, Relja, Chyla, Brenda, Xu, Tu, Dunbar, Martin, Agarwal, Suresh K, Humerickhouse, Rod, Mabry, Mack, Potluri, Jalaja, Konopleva, Marina, Pollyea, Daniel A
Published in The lancet oncology (01.02.2018)
Published in The lancet oncology (01.02.2018)
Get full text
Journal Article
Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine
Pollyea, Daniel A, Pratz, Keith W, Wei, Andrew H, Pullarkat, Vinod, Jonas, Brian A, Recher, Christian, Babu, Sunil, Schuh, Andre C, Dail, Monique, Sun, Yan, Potluri, Jalaja, Chyla, Brenda, DiNardo, Courtney D
Published in Clinical cancer research (15.12.2022)
Published in Clinical cancer research (15.12.2022)
Get full text
Journal Article
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine
Pratz, Keith W, Jonas, Brian A, Pullarkat, Vinod, Recher, Christian, Schuh, Andre C, Thirman, Michael J, Garcia, Jacqueline S, DiNardo, Courtney D, Vorobyev, Vladimir, Fracchiolla, Nicola S, Yeh, Su-Peng, Jang, Jun Ho, Ozcan, Muhit, Yamamoto, Kazuhito, Illes, Arpad, Zhou, Ying, Dail, Monique, Chyla, Brenda, Potluri, Jalaja, Döhner, Hartmut
Published in Journal of clinical oncology (10.03.2022)
Published in Journal of clinical oncology (10.03.2022)
Get full text
Journal Article
Impact of FLT3 Mutation on Outcomes after Venetoclax and Azacitidine for Patients with Treatment-Naïve Acute Myeloid Leukemia
Konopleva, Marina, Thirman, Michael J, Pratz, Keith W, Garcia, Jacqueline S, Recher, Christian, Pullarkat, Vinod, Kantarjian, Hagop M, DiNardo, Courtney D, Dail, Monique, Duan, Yinghui, Chyla, Brenda, Potluri, Jalaja, Miller, Catherine L, Wei, Andrew H
Published in Clinical cancer research (01.07.2022)
Published in Clinical cancer research (01.07.2022)
Get full text
Journal Article
Azacitidine and Venetoclax in AML. Reply
DiNardo, Courtney D, Wang, Jianxiang, Pratz, Keith W
Published in The New England journal of medicine (19.11.2020)
Published in The New England journal of medicine (19.11.2020)
Get full text
Journal Article
FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML
Pratz, Keith W., Sato, Takashi, Murphy, Kathleen M., Stine, Adam, Rajkhowa, Trivikram, Levis, Mark
Published in Blood (18.02.2010)
Published in Blood (18.02.2010)
Get full text
Journal Article
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 study
Stein, Eytan M., DiNardo, Courtney D., Fathi, Amir T., Mims, Alice S., Pratz, Keith W., Savona, Michael R., Stein, Anthony S., Stone, Richard M., Winer, Eric S., Seet, Christopher S., Döhner, Hartmut, Pollyea, Daniel A., McCloskey, James K., Odenike, Olatoyosi, Löwenberg, Bob, Ossenkoppele, Gert J., Patel, Prapti A., Roshal, Mikhail, Frattini, Mark G., Lersch, Frederik, Franovic, Aleksandra, Nabhan, Salah, Fan, Bin, Choe, Sung, Wang, Hongfang, Wu, Bin, Hua, Lei, Almon, Caroline, Cooper, Michael, Kantarjian, Hagop M., Tallman, Martin S.
Published in Blood (01.04.2021)
Published in Blood (01.04.2021)
Get full text
Journal Article
AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
Zarrinkar, Patrick P., Gunawardane, Ruwanthi N., Cramer, Merryl D., Gardner, Michael F., Brigham, Daniel, Belli, Barbara, Karaman, Mazen W., Pratz, Keith W., Pallares, Gabriel, Chao, Qi, Sprankle, Kelly G., Patel, Hitesh K., Levis, Mark, Armstrong, Robert C., James, Joyce, Bhagwat, Shripad S.
Published in Blood (01.10.2009)
Published in Blood (01.10.2009)
Get full text
Journal Article
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
McCurdy, Shannon R, Kasamon, Yvette L, Kanakry, Christopher G, Bolaños-Meade, Javier, Tsai, Hua-Ling, Showel, Margaret M, Kanakry, Jennifer A, Symons, Heather J, Gojo, Ivana, Smith, B Douglas, Bettinotti, Maria P, Matsui, William H, Dezern, Amy E, Huff, Carol Ann, Borrello, Ivan, Pratz, Keith W, Gladstone, Douglas E, Swinnen, Lode J, Brodsky, Robert A, Levis, Mark J, Ambinder, Richard F, Fuchs, Ephraim J, Rosner, Gary L, Jones, Richard J, Luznik, Leo
Published in Haematologica (Roma) (01.02.2017)
Published in Haematologica (Roma) (01.02.2017)
Get full text
Journal Article
Phase 1 study of quizartinib in combination with induction and consolidation chemotherapy in patients with newly diagnosed acute myeloid leukemia
Altman, Jessica K., Foran, James M., Pratz, Keith W., Trone, Denise, Cortes, Jorge E., Tallman, Martin S.
Published in American journal of hematology (01.02.2018)
Published in American journal of hematology (01.02.2018)
Get full text
Journal Article
Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide
McCurdy, Shannon R., Kanakry, Jennifer A., Showel, Margaret M., Tsai, Hua-Ling, Bolaños-Meade, Javier, Rosner, Gary L., Kanakry, Christopher G., Perica, Karlo, Symons, Heather J., Brodsky, Robert A., Gladstone, Douglas E., Huff, Carol Ann, Pratz, Keith W., Prince, Gabrielle T., Dezern, Amy E., Gojo, Ivana, Matsui, William H., Borrello, Ivan, McDevitt, Michael A., Swinnen, Lode J., Smith, B. Douglas, Levis, Mark J., Ambinder, Richard F., Luznik, Leo, Jones, Richard J., Fuchs, Ephraim J., Kasamon, Yvette L.
Published in Blood (07.05.2015)
Published in Blood (07.05.2015)
Get full text
Journal Article
Cost-Effectiveness Analysis of Venetoclax in Combination with Azacitidine Versus Azacitidine Monotherapy in Patients with Acute Myeloid Leukemia Who are Ineligible for Intensive Chemotherapy: From a US Third Party Payer Perspective
Pratz, Keith W., Chai, Xinglei, Xie, Jipan, Yin, Lei, Nie, Xiaoyu, Montez, Melissa, Iantuono, Erica, Downs, Lisa, Ma, Esprit
Published in PharmacoEconomics (01.08.2022)
Published in PharmacoEconomics (01.08.2022)
Get full text
Journal Article
Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults
Kasamon, Yvette L, Bolaños-Meade, Javier, Prince, Gabrielle T, Tsai, Hua-Ling, McCurdy, Shannon R, Kanakry, Jennifer A, Rosner, Gary L, Brodsky, Robert A, Perica, Karlo, Smith, B Douglas, Gladstone, Douglas E, Swinnen, Lode J, Showel, Margaret M, Matsui, William H, Huff, Carol Ann, Borrello, Ivan, Pratz, Keith W, McDevitt, Michael A, Gojo, Ivana, Dezern, Amy E, Shanbhag, Satish, Levis, Mark J, Luznik, Leo, Ambinder, Richard F, Fuchs, Ephraim J, Jones, Richard J
Published in Journal of clinical oncology (01.10.2015)
Published in Journal of clinical oncology (01.10.2015)
Get full text
Journal Article